Welcome to the LMNTIC blog
This is the first post on the LMNTIC blog. Here's what we plan to write about — and why circulating tumor cells are worth this much attention.
Why circulating tumor cells
Circulating tumor cells (CTCs) are cancer cells that have left a tumor and are travelling in the bloodstream. They are vanishingly rare among the billions of normal cells in a blood sample, which is exactly what makes them both hard to isolate and worth studying: a blood draw is far less invasive than a tissue biopsy, and the cells themselves carry intact protein and nucleic-acid information.
The Cell Circuit approach
LMNTIC's core technology is the Cell Circuit — patterned soft-magnetic microstructures that act as circuit elements for cells, trapping, transporting, and gating them on a chip. Realized in the L:Cell chip, it is the basis for L:Biopsy: one-step, ultra-pure isolation of CTCs directly from whole blood.
Most of what we build sits downstream of that idea — from counting and staining captured cells to preparing them for DNA and protein analysis.
What we'll cover
- The science — CTCs, liquid biopsy, and what a captured cell can tell you.
- The engineering — microfluidics, magnetophoresis, and the chip.
- The work in progress — how our research-use, pharma, and clinical directions are developing, written honestly about what is established and what is still ahead.
We'll keep it grounded: we explain mechanisms and approaches, and we cite real evidence when we have it rather than reaching for numbers we can't stand behind.
Get in touch
LMNTIC builds L:Biopsy for researchers and partners working with circulating tumor cells. If that's you, we'd like to hear from you — reach us at lmntic.com.